Armenia’s public debt amounts to over $9.3 billion

YEREVAN, April 6. /ARKA/. Armenia’s public debt as of February 28, 2022 stood at over $9.3 billion, up $41.7 million from January 31, 2022, according to the National Statistical Committee (NSC). On December 31, 2021 the country’s public debt stood at $9,225,643,000.

In Armenian drams, the public debt as of February 28, 2022 was worth about 4.5 trillion, decreasing by about 16 billion drams.

According to the National Statistics Committee, Armenia’s external debt stood at $6,648.842, 000, a decrease of $6.540 million from the previous month, while domestic debt rose by $48.253 million to $2,675.457, 000.

In AMD equivalent, the external debt decreased by over 6 billion to 3,205,539,500, while the domestic debt increased by 22.1 billion to 1,289,891,500.

The government’s external debt decreased by $13.345 million to $6,171.636, 000, while the Central Bank’s debt rose by $6.804 million to $477,206,000. In drams, the Central Bank’s debt rose by over 3 billion drams to 230 billion.

Of the domestic debt about $2,500,081,000 were owed to resident holders of government bonds, an increase of $43.243 million. Also, some $160.270 million were owed to resident holders of government bonds in foreign currency, an increase of $5 million.  Also, $11.106 million were owed as government guarantees, up $0.010 million. -0-

spot_img

POPULAR

US dollar, euro, and ruble up against  Armenian dram

YEREVAN, August 20. /ARKA/. The average market exchange rate for the US dollar to the Armenian dram on the Armenian foreign exchange market as of August 20, 2026, increased by 0.3 points to 365.26 drams compared to August 19.

US dollar, euro, and ruble drop against Armenian dram

YEREVAN, August 18. /ARKA/. The average market exchange rate for the US dollar against the Armenian dram on the Armenian foreign exchange market as of August 18, 2026, fell by 0.25 points to 365.25 drams compared to August 17.

“Solis” CJSC’s bonds listed on Armenia Stock Exchange

YEREVAN, August 18. /ARKA/. The range of companies listed on the Armenia Stock Exchange (AMX) continues to expand, contributing to the development of the capital market and creating new opportunities for businesses.

Shares of Noubar Afeyan’s Moderna soared 124% on news of a successful cancer vaccine trial

YEREVAN, August 20. /ARKA/. Shares of the biotech company Moderna soared 123.6% at the start of trading in the US on August 19, reaching a peak of $140.77, according to trading data. Shares of the pharmaceutical company Merck also rose 11.6% to $150.85, according to Forbes.ru.

Armenia set to enhance development of its capital market, targeting large issuers and new investors

YEREVAN, August 20. /ARKA/. The Armenian government prioritizes diversifying funding sources and advancing the capital market to foster sustainable and productive economic growth.

LATEST NEWS

spot_imgspot_imgspot_img